Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
India ranks second after China in the global diabetes epidemic, with 77 million people suffering from the condition in the ...
This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback